Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prosthetic Smart Socket Technology to Improve Patient Interaction, Usability, Comfort, Fit, and Function.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03199222
Recruitment Status : Recruiting
First Posted : June 26, 2017
Last Update Posted : March 20, 2019
Sponsor:
Collaborator:
U.S. Army Medical Research Acquisition Activity
Information provided by (Responsible Party):
University of South Florida

Brief Summary:
A common problem for the intermediate preparatory stage of prosthetic rehabilitation is distal pressure, due to commonly compromised sensation and lack of understanding how to address it in a newly fitted prosthesis. Excessive pressure can lead to severe skin breakdown, infection, surgical revision, re-hospitalization and delayed rehab. To prevent this common problem among rehabilitating amputees, smart socket technology has been developed to better identify problems that may occur. The Smart Socket Technology including Prompting (SST+P) in this pre-clinical project proposal provides a step activity monitor and senses distal pressure, which is novel to the technology. When excessive pressure is sensed on the residual limb, it will send a signal to the user's smart phone to make an adjustment. This prompting improves patient interaction and may prevent problems as a result of common volume fluctuation and compromised sensation. The purpose of this clinical trial is to determine if the ALPS iForce smart socket technology with prompting (SST+P) will improve patient interaction, usability, comfort, fit, function and health economy outcomes compared with the standard of care (SOC) clinical practice protocols of fitting prosthetic socket interfaces

Condition or disease Intervention/treatment Phase
Complications of the Amputated Limb Device: Prosthetic smart socket technology with patient prompting Not Applicable

Detailed Description:

Limb loss requires prosthetic use. Prostheses usually consist of 2 components: 1) a soft interface to protect the skin and underlying musculoskeletal tissue and 2) a structural interface to enable attachment of prosthetic components to the human body. The interface connects the patient's body to the prosthetic components and thus ground during gait. The interface has 2 purposes: 1) to distribute weight-bearing forces throughout the entire residual limb (RL) and 2) to suspend the prosthesis during swing phase and unweighting. The interface assists in distributing vertical loads during weight bearing to minimize focal loading on pressure intolerant tissues. The interface also suspends prosthetic components to the RL in swing phase and other periods of unweighting.

Many amputees experience RL complications and decreased mobility resulting from the inability to detect excess pressure or a lack of distal contact with newly fit and poorly fit interfaces. A smart socket technology interface could benefit every new prosthetic patient by prompting the user of a compromised socket fit prior to inhibiting functional use and safety. Further, the smart socket technology interface may ultimately prevent other health complications and improve patient interaction, usability, comfort, fit and function. The ALPS iForce most economically measures these variables more comprehensively than any other known single device. Therefore the smart socket interface technology chosen for this proposal is the ALPs iForce. The iForce tracks pressure over time and indicates to the user when positive or negative distal pressure exists by providing volume management suggestions (i.e. sock-ply adjustments). The user interacts with data measured sent wirelessly to an application on a smart phone (Android/iOS/Windows), handheld device, or PC. Suggestions may include removal or application of prosthetic socks over the RL, or other appropriate volume management strategies, to improve fit and comfort. Early warning to possible skin irritation and breakdown may lead to a healthier limb.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Other
Official Title: Prosthetic Smart Socket Technology to Improve Patient Interaction, Usability, Comfort, Fit, and Function.
Actual Study Start Date : March 29, 2018
Estimated Primary Completion Date : May 2019
Estimated Study Completion Date : July 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Drug Reactions

Arm Intervention/treatment
Experimental: Arm 1: Smart socket technology w/patient prompting
The prosthetic user WILL receive prompting by the smart socket technology regarding improper fit and suggestions for how to a restore a proper fit (i.e socks). Investigators will have access to the Smart Socket Technology database.
Device: Prosthetic smart socket technology with patient prompting
The smart socket technology will send feedback to the user's smartphone with suggestions including the removal or application of prosthetic socks over the residual limb or other volume management strategies to improve fit and comfort.

No Intervention: Arm 2: Clinical protocol. No patient prompting
The prosthetic user WILL NOT receive prompting by the smart socket technology regarding improper fit and suggestions for how to a restore a proper fit (i.e socks). However, investigators will have access to the Smart Socket Technology database.



Primary Outcome Measures :
  1. Intermediate stage prosthetic complications [ Time Frame: Will be tracked for 120 days. ]
    Clinical documentation will track incidence of dermatologic issues, skin breakdown, sock ply, circumference, infection and wound severity.

  2. Limb volume activity of the residual limb [ Time Frame: Will be tracked for 120 days ]
    Limb volume will be tracked through clinical documentation including residual limb volumetrics (circumferential measurements), sock-ply changes (journal), and required interface changes will be used to record volume activity and corresponding consequence and management strategies.

  3. Intermediate stage prosthetic complications (clinical documentation) [ Time Frame: Will be tracked for 120 days ]
    Re-hospitalization rate

  4. Intermediate stage prosthetic complications (clinical documentation) [ Time Frame: Will be tracked for 120 days ]
    Revision rate will be documented


Secondary Outcome Measures :
  1. Balance and Stability [ Time Frame: 30 days post-amputation and at end of trial (120 days) ]
    Post-amputation balance and stability will be tested with the Amputee Mobility Predictor (AMP). The AMP is a brief physical assessment (≈15min to administer) to objectively determine a lower extremity amputee's functional level. Subjects are assessed by progressing through a hierarchy of mobility tasks including sitting balance, standing balance, obstacle crossing, variable gait speed and stair gait.

  2. Mobility [ Time Frame: 30 days post-amputation and at end of trial (120 days) ]

    L-Test of Functional Mobility and the 2 minute walk test will be used to assess mobility. The L-Test is practical in design and intended to be used in a standard clinical hallway.29 Subjects begins the test seated in a chair.

    The patient rises from the chair, walks three meters, turns 90 degrees and then walks an additional seven meters. Upon completing seven meters, the subject turns 180 degrees, returns, turns 90 degrees to face the chair, and returns the three meters to his chair, where they retake the seat.


  3. Step Activity [ Time Frame: 120 days ]
    The Smart Socket Technology in this proposal has the capability of measuring step count activity. Step activity monitoring is utilized to count the number of steps taken.

  4. Step Activity [ Time Frame: 120 days ]
    Step activity monitoring is used to count the duration of step bout activity per stepping episode.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Unilateral transtibial amputation
  2. Unilateral revision or reconstruction of transtibial amputation
  3. Candidate for intermediate stage (i.e. preparatory) socket fitting
  4. Male or female, of any ethnicity
  5. 18-60 yrs of age (i.e. active military age)
  6. 100-275 lbs.

Exclusion Criteria:

  1. Body weight <100 or >275 lbs
  2. Does not speak English or Spanish
  3. Any other level of amputation than unilateral TTA

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03199222


Contacts
Layout table for location contacts
Contact: Jason Highsmith, PhD 813-625-5406 michael.highsmith@va.gov

Locations
Layout table for location information
United States, Florida
University of South Florida Recruiting
Tampa, Florida, United States, 33612
Contact: M. Jason Highsmith, DPT, CP    813-974-3806    mhighsmi@health.usf.edu   
Sponsors and Collaborators
University of South Florida
U.S. Army Medical Research Acquisition Activity
Investigators
Layout table for investigator information
Principal Investigator: Jason Highsmith, PhD University of South Florida

Layout table for additonal information
Responsible Party: University of South Florida
ClinicalTrials.gov Identifier: NCT03199222     History of Changes
Other Study ID Numbers: Pro00026455
First Posted: June 26, 2017    Key Record Dates
Last Update Posted: March 20, 2019
Last Verified: March 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University of South Florida:
amputation
transtibial
socket
pressure